Form D · Biotechnology
BRAINSTORM CELL THERAPEUTICS INC.
New York, NY · CIK 0001137883
Offering snapshot reported Aug 9, 2019 · SEC filing
- Reported sold
- $0 Indefinite offering
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 2, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 9, 2019 | Initial | $0 | No comparison | 3 | SEC filing |
| Jun 20, 2018 | Initial | $0 | No comparison | 6 | SEC filing |
| Jan 21, 2015 | Initial | $0 | No comparison | 8 | SEC filing |
| Jul 1, 2014 | Initial | $10,500,000 | No comparison | 11 | SEC filing |
| May 9, 2014 | Initial | $1,632,689 | No comparison | 8 | SEC filing |
| Jul 27, 2012 | Initial | $206,910 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-346264
842,000 warrants to purchase stock were issued in consideration of the August 2, 2019 agreement by certain existing warrant holders to exercise existing warrants.
Source: Form D, filed Aug 9, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dr. June Almenoff | Director |
| Arturo Araya | Executive |
| Irit Arbel | Director |
| Dr. Irit Arbel | Director |
| Anthony Fiorino | Executive |
| Mordechai Friedman | Director |
| Adrian Harel | Executive |
| Abraham Israeli | Director |
| Ralph Kern | Executive |
| Chaim Lebovits | Executive |
| Alon Pinkas | Director |
| Dr. Anthony Polverino | Director |
| Eyal Rubin | Executive |
| Chen Schor | Director |
| Robert Shorr | Director |
| Liat Sossover | Executive |
| Malcolm Taub | Director |
| Uri Yablonka | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1325 Avenue Of Americas, 28 Th Floor
New York, NY, 10019
New York, NY, 10019